Feedback / Questions
Elayta (CT1812) - Cognition Therap
https://www.globenewswire.com/news-release/2020/08/27/2084719/0/en/Cognition-Therapeutics-Announces-First-Patient-Dosed-in-SEQUEL-Study-of-CT1812.html
Aug 27, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next